Axsome Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $19M | 212k | 89.87 |
| 2024-06-30 | $15M | 185k | 80.50 |
| 2024-03-31 | $16M | 195k | 79.80 |
| 2023-12-31 | $15M | 190k | 79.59 |
| 2023-09-30 | $12M | 173k | 69.89 |
| 2023-06-30 | $12M | 173k | 71.86 |
| 2023-03-31 | $11M | 174k | 61.57 |
| 2022-12-31 | $13M | 168k | 77.13 |
| 2022-06-30 | $6.7M | 176k | 38.31 |
| 2022-03-31 | $7.3M | 176k | 41.39 |
| 2021-12-31 | $6.6M | 175k | 37.78 |
| 2021-03-31 | $1.3M | 24k | 56.64 |
| 2020-12-31 | $1.9M | 24k | 81.48 |
| 2020-09-30 | $727k | 10k | 69.77 |
| 2020-06-30 | $728k | 9.5k | 76.92 |
| 2020-03-31 | $426k | 8.7k | 48.78 |
| 2019-12-31 | $837k | 8.1k | 103.41 |
| 2019-09-30 | $921k | 46k | 20.24 |
| 2019-06-30 | $170k | 6.7k | 25.41 |
| 2018-09-30 | $140k | 41k | 3.44 |
| 2018-06-30 | $261k | 82k | 3.20 |
| 2018-03-31 | $442k | 180k | 2.45 |
| 2017-12-31 | $8.2M | 1.5M | 5.60 |
| 2017-06-30 | $8.0M | 1.4M | 5.54 |
| 2017-03-31 | $6.2M | 1.6M | 3.90 |
| 2016-12-31 | $11M | 1.6M | 6.75 |
| 2016-09-30 | $13M | 1.6M | 7.88 |
| 2016-06-30 | $12M | 1.6M | 7.54 |
| 2016-03-31 | $14M | 1.6M | 8.60 |
| 2015-12-31 | $14M | 1.6M | 9.13 |